Category: Malaria
North America Malaria
-
2024-2029 Malaria Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Malaria tests performed in the following market segments: Hospitals - Commercial/Private Labs - Physician ... Read More
-
2024 Global Malaria Diagnostics Market: US, Europe, Japan - Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
... US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the ... Read More
-
Infectious Disease Diagnostics Market, By Technique ( ELISA, Polymerase Chain Reaction (PCR),Immunoassays, Cell Cultures, Others),By Disease Indication (CNS Infection ,Meningitis, Brain Abscess), Diarrheal Disease ( Shigellosis, Cholera, Enteric/Typhoid Fever),Respiratory Infections(Tuberculosis, Influenza, Bronchitis),Blood Infections(Malaria, Dengue, Infectious Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... Mononucleosis, Others),STDs(Chlamydia, Aids, Syphills, Others)),By End User (Hospitals, Diagnostic Centers, Clinics, Government Organizations), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - ... Read More
-
North America Malaria Treatment Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment Type (Antimalarial Agents, and Diagnostic Test); Route of Administration (Oral, and Parenteral); End User (Hospitals, Specialty Clinics, and Others)
... The North America malaria treatment market is expected to grow from US$ 765.63 million in 2022 to US$ 996.80 million by 2028. It is estimated to register a CAGR of 4.5% from 2022 to 2028. ... Read More
-
Malaria Vaccines Market, by Agent (Plasmodium Falciparum, Plasmodium Vivax and Anopheles Species), by Vaccine Type (Pre-Erythrocytic, Erythrocytic and Multi-antigen), by Distribution Channel (Public and Private) and by Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It ... Read More
-
Pyrimethamine Market, by Indication (Toxoplasmosis, Malaria, and Others), by Route of Administration (Parenteral and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia
... Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pyrimethamine is a medicine used to treat protozoan infections. Pyrimethamine belongs to a class of drugs known as antiparasitics. It works ... Read More
-
Hydroxychloroquine Market, By Disease Indication (Malaria, Coronavirus Disease, Lupus Erythematosus, and Rheumatoid Arthritis), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin Am
... and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hydroxychlorquine has exhibits the potential invitro activity against viruses including influenza, malaria, coronavirus, and many other diseases. The drug is under investigation to ... Read More
-
2022-2026 Malaria Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Malaria tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices Public ... Read More
-
Pyrimethamine Market, by Indication (Toxoplasmosis, Malaria, and Others), by Route of Administration (Parenteral and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pyrimethamine is a medicine used to treat protozoan infections. Pyrimethamine belongs to a class of drugs known as antiparasitics. It works ... Read More
-
Vaccines Market, by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Toxoid Therapy, and Recombinant Therapy), by Type (Monovalent Vaccines and Multivalent Vaccines), by Indication (Typhoid, Hepatitis, Pneumococcal, DTP, Malaria, Influenza, Human Papilloma Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Virus, Meningococcal, Polio, Rotavirus, MMR, Varicella, Herpes Zoster, and Others), by Route of Administration (Parenteral Administration and Oral Administration), by Age Group (Pediatric and Adult), and by Region (North America, Latin America, Europe, Asia Pacific, ... Read More